Ovarian cancer gene therapy

Hematology/Oncology Clinics of North America

Volumn 12, Issue 3, 1998, Pages 539-552

  Tait, D L ^a   Obermiller, P S ^a   Jensen, R A ^a   Holt, J T ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

CLINICAL PROTOCOL; CLINICAL TRIAL; GENE TARGETING; GENE THERAPY; HETEROZYGOSITY LOSS; HUMAN; OVARY CANCER; PRIORITY JOURNAL; QUALITY CONTROL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

EID: 0031825549     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70007-1     Document Type: Article

References (34)

1. C.L. Arteaga J.T. Holt Tissue-targeted antisense anti-fos retroviral vector inhibits established breast cancer in nude mice xenografts Cancer Res 56 1996 1098 1103
2. S.K. Ayesh Y. Azar I.I. Barghouti Purification and characterization of a C5a-inactivating enzyme from human peritoneal fluid Blood 85 1995 3503 3509
3. M.S. Chapman I.M. Verma Transcriptional activation by BRCA1 [letter] Nature 382 1996 678 679
4. Y. Chen C.F. Chen D.J. Riley Aberrant subcellular localization of BRCA1 in breast cancer Science 270 1995 789 791
5. L.S. Friedman E.A. Ostermeyer C.I. Szabo Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families Nat Genet 8 1994 399 404
6. P.A. Futreal Q. Liu D. Shattuck-Eidens BRCA1 mutations in primary breast and ovarian carcinomas Science 266 1994 120 122
7. S.A. Gayther S. Mazoyer W. Warren Germline mutations of the BRCA1 gene in breast/ovarian cancer families: Evidence for a genotype/phenotype correlation Nat Genet 11 1995 428 433
8. Hakem R. de la Pompa J.L. C. Sirard The tumor suppressor gene Brca1 is required for embryonic proliferation in the mouse Cell 85 1996 1009 1023
9. J.M. Hall M.K. Lee B. Newman Linkage of early-onset breast cancer to chromosome 17q21 Science 250 1990 1684 1689
10. J.T. Holt M.E. Thompson C. Szabo Growth retardation and tumor inhibition by BRCA1 Nat Genet 12 1996 298 302
11. L. Hosking J. Trowsdale H. Nicolai A somatic BRCA1 mutation in an ovarian tumor Nat Genet 9 1995 343 344
12. R.A. Jensen M.E. Thompson C. Szabo BRCA1 is secreted and exhibits properties of a granin Nat Genet 12 1996 303 308
13. K.W. Kinzler B. Vogelstein Gatekeepers and caretakers Nature 386 1997 761 763
14. T.F. Lane C. Deng A. Elson Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice Genes Dev 9 1995 2712 2722
15. S.T. Marquis J.V. Rajan A. Wynshaw-Boris The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues Nat Genet 11 1995 17 26
16. S.D. Merajver T.M. Pham R.F. Caduff Somatic mutations in the BRCA1 gene in sporadic ovarian tumors Nat Genet 9 1995 439 443
17. Y. Miki J. Swensen D. Shattuck-Eidens A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
18. A.N. Monteiro A. August H. Hanafusa Evidence for a transcriptional activation function of BRCA1 C-terminal region Proc Natl Acad Sci USA 93 1996 13595 13599
19. M.N. Pensiero C.A. Wysocki K. Nader G.E. Kikuchi Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum Hum Gene Ther 7 1996 1095 1101
20. V.N. Rao N. Shao M. Ahmad E.S. Reddy Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts Oncogene 12 1996 523 528
21. S.A. Rollins C.W. Birks E. Setter Retroviral vector producer cell killing in human serum by natural antibody and complement: Strategies for evading the humoral immune response Hum Gene Ther 7 1996 619 626
22. J.A. Roth R.J. Cristiano Gene therapy for cancer: What have we done and where are we going? J Natl Cancer Inst 89 1997 21 39
23. J.A. Roth D. Nguyen D.D. Lawrence Retroviral mediated wildtype p53 gene transfer to tumors of patients with lung cancer Nature Medicine 2 1996 985 991
24. R.P. Rother S.P. Squinto J.M. Mason S.A. Rollins Protection of retroviral vector particles in human blood through complement inhibition Hum Gene Ther 6 1995 429 435
25. R.P. Rother W.L. Fodor J.P. Springhorn A novel mechanism of retrovirus inactivation in human serum mediated by anti–alpha-galactosyl natural antibody J Exp Med 182 1995 1345 1355
26. R. Scully S. Ganesan M. Brown Location of BRCA1 in human breast and ovarian cancer cells [letter] Science 272 1996 123 126
27. R. Scully J. Chen A. Plug Association of BRCA1 with Rad51 in mitotic and meiotic cells Cell 88 1997 265 275
28. N. Shao Y.L. Chai E. Shyam Induction of apoptosis by the tumor suppressor protein BRCA1 Oncogene 13 1996 1 7
29. D.L. Tait P.S. Obermiller S. Redlin-Frazier A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer Clin Cancer Res 3 1997 1959 1968
30. H. Takahashi K. Behbakht P.E. McGovern Mutation analysis of the BRCA1 gene in ovarian cancers Cancer Res 55 1995 2998 3002
31. M.E. Thompson R.A. Jensen P.S. Obermiller Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression Nat Genet 9 1995 444 450
32. R.M. Welsh N.R. Cooper F.C. Jensen M.B.A. Oldstone Human serum lysis RNA tumor viruses Nature 257 1975 612 614
33. C.A. Wilson M.N. Payton S.K. Pekar BRCA1 protein products: Antibody specificity [letter] Nat Genet 13 1996 264 265
34. C.A. Wilson M.N. Payton G.S. Elliott Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta1 1b Oncogene 14 1997 1 16